PROPHESYS 3: Observational Study on Predictors of Response in Patients With Treatment-naïve Chronic Hepatitis C Initiated on Treatment With Pegasys (Peginterferon Alfa-2a) or Peginterferon-alfa-2b

Clinical trial NCT01066819 · COMPLETED

Trial details

NCT number: NCT01066819
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Study type: OBSERVATIONAL

Hepatitis C, Chronic

Start date: 2008-01-01
Primary completion: 2011-08-01
Enrollment: 1656

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.